Spectral AI EBITDA Margin 2021-2024 | MDAI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Spectral AI (MDAI) over the last 10 years. The current EBITDA margin for Spectral AI as of December 31, 2024 is .
| Spectral AI EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-12-31 | $0.03B | $-0.01B | -20.69% |
| 2024-09-30 | $0.03B | $-0.01B | -30.77% |
| 2024-06-30 | $0.02B | $-0.01B | -52.38% |
| 2024-03-31 | $0.02B | $-0.01B | -66.67% |
| 2023-12-31 | $0.02B | $-0.01B | -76.47% |
| 2023-09-30 | $0.03B | $-0.01B | -36.67% |
| 2023-06-30 | $0.03B | $-0.01B | -20.59% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.032B | $0.030B |
| Spectral MD Holdings Ltd. is a predictive AI company focused on medical diagnostics. The Company's DeepView(R) platform is a predictive diagnostic device which offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. Spectral MD Holdings Ltd., formerly known as ROSECLIFF ACQ, is based in DALLAS. | |||